|
Volumn 30, Issue 12, 2003, Pages 1873-1880
|
Chemotherapy for esophageal cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CF REGIMEN;
CISPLATIN;
DRUG DERIVATIVE;
FLUOROURACIL;
MITOMYCIN;
NAVELBINE;
VINBLASTINE;
ADJUVANT THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
ESOPHAGUS TUMOR;
HUMAN;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CISPLATIN;
ESOPHAGEAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
MITOMYCIN;
NEOADJUVANT THERAPY;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL RATE;
VINBLASTINE;
|
EID: 0642272520
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (4)
|
References (42)
|